NR1D1 and neoplasm: Our additional ChIP-seq analysis with a de novo NEPC PDX tumor (LuCaP173.1) demonstrated that REV-ERBα ChIP-seq peaks in the PDX tumor are largely overlapping with the peaks in 42DENZR cells (SI Appendix, Fig. S4B and Dataset S2).